Reading INFU? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track INFU free→Reading INFU? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track INFU free→QuarterlyIQ Insights · INFU
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Regulation FD Disclosure On May 18, 2026, InfuSystem Holdings, Inc. (the “Company”) issued a press release announcing that the Company’s Board of Directors has approved a stock repurchase program authorizing the Company to repurchase up to $20 million of the Company’s outstanding common stock starting on July 1, 2026 and running through through June 30, 2028. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information furnished in this
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Following the 2026 Annual Meeting of Stockholders of InfuSystem Holdings, Inc. held on May 11, 2026, the newly constituted Board of Directors elected Beverly Huss to serve as the Chairman of the Board of Directors. There are no arrangements or understandings between Ms. Huss and any other persons, pursuant to which she was appointed as Chairman, no…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. At the 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”) of InfuSystem Holdings, Inc. (the “Company”) held on May 11, 2026, the Company's stockholders approved the Third Amendment (the “Third Amendment”) to the InfuSystem Holdings, Inc. 2021 Equity Incentive Plan (as amended, the “2021 Plan”), which was previously approved by the Comp…
“Results of Operations and Financial Condition” of this Current Report on Form 8-K and the press release attached hereto as Exhibit 99.1 shall not be deemed “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of such section, and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.
Changes in Registrant's Certifying Accountant The Audit Committee (the "Committee") of the Board of Directors of InfuSystem Holdings, Inc. (the "Company") conducted a competitive selection process to determine the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. The Committee invited several firms to participate in this process, including Deloitte & Touche LLP ("Deloitte"), the Company's independent registered public accounting firm for the…
“Results of Operations and Financial Condition” of this Current Report on Form 8-K and the press release attached hereto as Exhibit 99.1 shall not be deemed “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of such section, and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.
“Results of Operations and Financial Condition” of this Current Report on Form 8-K and the press release attached hereto as Exhibit 99.1 shall not be deemed “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of such section, and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.
“Results of Operations and Financial Condition” of this Current Report on Form 8-K and the press release attached hereto as Exhibit 99.1 shall not be deemed “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of such section, and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The disclosure contained in
Entry into a Material Definitive Agreement. On July 15, 2025, InfuSystem Holdings, Inc. (the “Company”) together with its direct and indirect subsidiaries (collectively, the “Borrowers”), entered into a Second Amendment to Credit Agreement (the “Amendment”) with JPMorgan Chase Bank, N.A., as administrative agent (the “Administrative Agent”), and the lenders party thereto, which amended the Credit Agreement, dated as of February 5, 2021 (as amended by the First and Second Amendments, the “Cred…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On May 29, 2025, InfuSystem Holdings, Inc. (the “Company”) entered into a Second Amended and Restated Employment Agreement with its President and Chief Executive Officer Carrie Lachance (the “Second Amended Agreement”). The Second Amended Agreement reflects changes in Ms. Lachance’s compensation and other terms of employment in connection with her…
Material Modification to Rights of Security Holders The information set forth in
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. At the 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”) of InfuSystem Holdings, Inc. (the “Company”) held on May 15, 2025, the Company's stockholders approved the Second Amendment (the “Second Amendment”) to the InfuSystem Holdings, Inc. 2021 Equity Incentive Plan (as amended, the “2021 Plan”), which was previously approved by the Co…
“Results of Operations and Financial Condition” of this Current Report on Form 8-K and the press release attached hereto as Exhibit 99.1 shall not be deemed “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of such section, and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Departure of Chief Executive Officer and Appointment of Incoming Chief Executive Officer On April 1, 2025, InfuSystem Holdings, Inc. (the “Company”) announced that the Company's Board of Directors (the "Board") and Richard A. DiIorio have agreed that Mr. DiIorio will step down as the Company's Chief Executive Officer ("CEO"), effective May 19, 2025…
“Results of Operations and Financial Condition” of this Current Report on Form 8-K and the press release attached hereto as Exhibit 99.1 shall not be deemed “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of such section, and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.